From June 23, 2022 to June 30, 2022, the company has repurchased 10,936 shares, representing 0.05% for KRW 82.05 million. With this, the company has completed the repurchase of 10,936 shares, representing 0.05% for KRW 82.05 million under the buyback announced on June 23, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
5,190 KRW | -0.38% | 0.00% | -9.90% |
2023 | Dong Sung Bio Pharm.Co.,Ltd. announced that it has received KRW 14 billion in funding | CI |
2023 | Dong Sung Bio Pharm.Co.,Ltd. announced that it expects to receive KRW 14 billion in funding | CI |
1st Jan change | Capi. | |
---|---|---|
-9.90% | 87.7M | |
+21.63% | 44.11B | |
+23.03% | 22.71B | |
+18.22% | 15.15B | |
+12.66% | 13.56B | |
+60.18% | 12.7B | |
-10.02% | 6.84B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+12.92% | 5.63B |
- Stock Market
- Equities
- A002210 Stock
- News Dong Sung Bio Pharm.Co.,Ltd.
- Tranche Update on Dong Sung Bio Pharm.Co.,Ltd.'s Equity Buyback Plan announced on June 23, 2022.